| 1 |
33402387 | Targeting the IRAK1-S100A9 Axis Overcomes Resistance to Paclitaxel in Nasopharyngeal Carcinoma. | 2021 Mar 1 |
2 |
| 2 |
33232476 | Determining the recommended dose of pacritinib: results from the PAC203 dose-finding trial in advanced myelofibrosis. | 2020 Nov 24 |
1 |
| 3 |
33275766 | Pacritinib demonstrates spleen volume reduction in patients with myelofibrosis independent of JAK2V617F allele burden. | 2020 Dec 8 |
1 |
| 4 |
29235894 | Pacritinib and its use in the treatment of patients with myelofibrosis who have thrombocytopenia. | 2018 Apr |
1 |
| 5 |
29616317 | Outcomes of patients with myelofibrosis treated with compassionate use pacritinib: a sponsor-independent international study. | 2018 Aug |
2 |
| 6 |
29743719 | Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypes. | 2018 Nov |
6 |
| 7 |
29785143 | Pilot study of the antifibrotic effects of the multikinase inhibitor pacritinib in a mouse model of liver fibrosis. | 2018 |
1 |
| 8 |
27931243 | Phase 1/2 study of pacritinib, a next generation JAK2/FLT3 inhibitor, in myelofibrosis or other myeloid malignancies. | 2016 Dec 8 |
2 |